Doubek M - Search Results

1

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.

Mraz M, Malinova K, Kotaskova J, Pavlova S, Tichy B, Malcikova J, Stano Kozubik K, Smardova J, Brychtova Y, Doubek M, Trbusek M, Mayer J, Pospisilova S. Mraz M, et al. Among authors: doubek m. Leukemia. 2009 Jun;23(6):1159-63. doi: 10.1038/leu.2008.377. Epub 2009 Jan 22. Leukemia. 2009. PMID: 19158830 No abstract available.

2

[Must we be really concerned about amphotericin B toxicity in oncology patients?].

Mayer J, Doubek M. Mayer J, et al. Among authors: doubek m. Cas Lek Cesk. 1998 Oct 19;137(20):632-6. Cas Lek Cesk. 1998. PMID: 9863267 Czech.

3

Must we really fear toxicity of conventional amphotericin B in oncological patients?

Mayer J, Doubek M, Vorlìcek J. Mayer J, et al. Among authors: doubek m. Support Care Cancer. 1999 Jan;7(1):51-5. doi: 10.1007/s005200050224. Support Care Cancer. 1999. PMID: 9926976

4

[Lymphocytosis with large granular lymphocytes: case report].

Brychtová Y, Doubek M, Mayer J, Bulíková A, Krahulová M. Brychtová Y, et al. Among authors: doubek m. Vnitr Lek. 2000 May;46(5):301-4. Vnitr Lek. 2000. PMID: 11227187 Czech.

5

[Safety of long-term administration of conventional amphotericin B in oncology patients].

Doubek M, Mayer J, Horký D. Doubek M, et al. Cas Lek Cesk. 2002 Mar;141(5):156-9. Cas Lek Cesk. 2002. PMID: 11998223 Czech.

6

Increased expression of fibroblast growth factor receptor 3 in CD34+ BCR-ABL+ cells from patients with chronic myeloid leukemia.

Dvorak P, Dvorakova D, Doubek M, Faitova J, Pacholikova J, Hampl A, Mayer J. Dvorak P, et al. Among authors: doubek m. Leukemia. 2003 Dec;17(12):2418-25. doi: 10.1038/sj.leu.2403152. Leukemia. 2003. PMID: 14562121

7

Reduced-intensity allografting for chronic myeloid leukemia in the first chronic phase.

Doubek M, Vitek A, Mayer J. Doubek M, et al. Haematologica. 2004 Apr;89(4):ELT03. Haematologica. 2004. PMID: 15075116 No abstract available.

8

Acute myeloid leukemias with recurrent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relapse with chemotherapy.

Doubek M, Brychtova Y, Berkovcova J, Krejci M, Palasek I, Dvorakova D, Mayer J. Doubek M, et al. Leukemia. 2005 May;19(5):885-8. doi: 10.1038/sj.leu.2403708. Leukemia. 2005. PMID: 15744338 No abstract available.

9

Idiopathic systemic capillary leak syndrome misdiagnosed and treated as polycythemia vera.

Doubek M, Brychtova Y, Tomiska M, Mayer J. Doubek M, et al. Acta Haematol. 2005;113(2):150-1. doi: 10.1159/000083455. Acta Haematol. 2005. PMID: 15802896 No abstract available.

10

Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease.

Krejci M, Doubek M, Buchler T, Brychtova Y, Vorlicek J, Mayer J. Krejci M, et al. Among authors: doubek m. Ann Hematol. 2005 Oct;84(10):681-5. doi: 10.1007/s00277-005-1070-0. Epub 2005 Jul 7. Ann Hematol. 2005. PMID: 16001244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters